Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension

由 Safdar, Zeenat
出版 2011

Pulmonary Hypertension: A Woman's Disease

由 Safdar, Zeenat
出版 2013

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

由 Jyothula, Soma, Safdar, Zeenat
出版 2009

Hemoptysis requiring bronchial artery embolization in pulmonary arterial hypertension: one center experience

由 Cantu, A., Safdar, Zeenat
出版 2010

Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms

由 Medrek, Sarah, Safdar, Zeenat
發表在 Methodist Debakey Cardiovasc J (2016)

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol

由 Abughazaleh, Shaadi, Safdar, Zeenat
發表在 Case Rep Pulmonol (2020)

Chronic Thromboembolic Pulmonary Hypertension Medical Management

由 Logue, Ryan, Safdar, Zeenat
發表在 Methodist Debakey Cardiovasc J (2021)

Pulmonary Hypertension Complicated by Pericardial Effusion: A Single Center Experience

由 Honeycutt, Gregory R., Safdar, Zeenat
出版 2012

Clinical Implications of Hemoptysis in Patients with Pulmonary Arterial Hypertension

由 Cantu, Jose, Wang, Degang, Safdar, Zeenat
出版 2012

Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension

由 Oriaku, Ifeoma, Patel, Amol, Safdar, Zeenat
發表在 Pulm Circ (2020)

Use of Extracorporeal Membrane Oxygenation in Postpartum Management of a Patient with Pulmonary Arterial Hypertension

由 Abid Memon, Humna, Safdar, Zeenat, Goodarzi, Ahmad
發表在 Case Rep Pulmonol (2018)

Inhibition of Acid-induced Lung Injury by Hyperosmolar Sucrose in Rats

由 Safdar, Zeenat, Yiming, Maimiti, Grunig, Gabriele, Bhattacharya, Jahar
出版 2005

Critical Role for IL-18 in Spontaneous Lung Inflammation Caused by Autophagy Deficiency()

由 Fattah, Elmoataz Abdel, Bhattacharya, Abhisek, Herron, Alan, Safdar, Zeenat, Eissa, N. Tony
發表在 J Immunol (2015)

Hyperosmolarity enhances the lung capillary barrier

由 Safdar, Zeenat, Wang, Ping, Ichimura, Hideo, Issekutz, Andrew C., Quadri, Sadiqa, Bhattacharya, Jahar
出版 2003

Collagen Metabolism Biomarkers and Health Related Quality of Life in Pulmonary Arterial Hypertension

由 Safdar, Zeenat, Tamez, Emilio, Frost, Adaani, Guffey, Danielle, Minard, Charles G, Entman, Mark L
發表在 Int J Cardiovasc Res (2015)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study

由 Safdar, Zeenat, Frost, Adaani, Basant, Arya, Deswal, Anita, O’Brian Smith, E., Entman, Mark
發表在 Pulm Circ (2020)

Circulating Aldosterone Levels and Disease Severity in Pulmonary Arterial Hypertension

由 Safdar, Zeenat, Thakur, Aishwarya, Singh, Supriya, Ji, Yingqun, Guffey, Danielle, Minard, Charles G, Entman, Mark L
發表在 J Pulm Respir Med (2015)

Management of Pulmonary Arterial Hypertension During Pregnancy: A Retrospective, Multicenter Experience

由 Duarte, Alexander G., Thomas, Shibu, Safdar, Zeenat, Torres, Fernando, Pacheco, Luis D., Feldman, Jeremy, deBoisblanc, Bennet
出版 2013

Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension

由 Medrek, Sarah K., Kloefkorn, Chad, Nguyen, Duc T.M., Graviss, Edward A., Frost, Adaani E., Safdar, Zeenat
發表在 Pulm Circ (2017)

Circulating Collagen Biomarkers as indicators of Disease Severity in Pulmonary Arterial Hypertension

由 Safdar, Zeenat, Tamez, Emilio, Chan, Wenyaw, Arya, Basant, Ge, Yimin, Deswal, Anita, Bozkurt, Biykem, Frost, Adaani, Entman, Mark
出版 2014